Patent intelligence · AU
AU 2010255748
Stabilised composition comprising at least one adrenergic compound
Stabilised composition comprising at least one adrenergic compound
Patent details — AU 2010255748
- Jurisdiction
- AU
- Status
- granted
- Grant date
- Dec 8, 2011
- Expiration
- Dec 3, 2031
- Applicant
- ALK AG [DK]
- CPC classes
- A61K 9/ 00 A I, A61K 31/ 137 A I, A61K 47/ 02 A I, A61K/31137
Quick answer
AU 2010255748 (Stabilised composition comprising at least one adrenergic compound) is held by ALK AG [DK]. Status: granted. Granted Dec 8, 2011. Expires Dec 3, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALK AG [DK]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 00 A I, A61K 31/ 137 A I, A61K 47/ 02 A I, A61K/31137, A61K/3304, A61K/4506
More from ALK AG [DK]
Related pharmaceutical patents in our USPTO index.
-
WO 2024200854
ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE
granted -
EP 4302751
ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT
granted -
EP 4302750
ORALE DÜNNFILME ENTHALTEND ADRENALIN
granted -
CA 3259886
DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI
granted -
WO 2023232958
INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE
granted -
CA 3255134
COMPOSITION D'ALLERGÈNE D'ARACHIDE
granted -
WO 2019224246
MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE
granted -
HK 1249412
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
granted
Frequently asked questions
What is US patent 2010255748?
AU 2010255748 (Stabilised composition comprising at least one adrenergic compound) is held by ALK AG [DK]. Status: granted. Granted Dec 8, 2011. Expires Dec 3, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AU 2010255748?
ALK AG [DK] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does AU 2010255748 expire?
Our index shows an expiration date of Dec 3, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.